Answers are grounded in this paper and cite their sources.
This phase II trial is the first randomized study demonstrating that aggressive local treatment can prolong OS in patients with unresectable colorectal liver metastases.
No takes yet. Share an insight, caveat, or question.
Ruers et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: